Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)Luigi Gargiulo, Antonio Costanzo, Elena Campione et al.|Frontiers in Medicine|2023Cited by 55
Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience—IL PSO (Italian Landscape Psoriasis)Diego Orsini, Antonio Costanzo, Piergiorgio Malagoli et al.|Dermatology Practical & Conceptual|2024Cited by 34
Anorectal melanoma: systematic review of the current literature of an aggressive type of melanomaGiovanni Paolino, Riccardo Pampena, Antonio Podo Brunetti et al.|Melanoma Research|2024Cited by 24
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis)Luigi Gargiulo, Alessandra Narcisi, Luciano Ibba et al.|Journal of Dermatological Treatment|2024Cited by 21
Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real‐life Italian multicenter observational study of 250 patientsGianluca Nazzaro, Angelo Valerio Marzano, Andrea Carugno et al.|International Journal of Dermatology|2024Cited by 18